Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0409974 (
lupus
)
22,386
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
10 consecutive patients fulfilled the diagnostic criteria for
lupus
anticoagulant. 4 had concomitant systemic lupus erythematosus, 1
Waldenstrom's disease
and 5 had no apparent underlying disease. Only the case with
Waldenstrom's disease
presented a bleeding tendency, with bleeding time greater than 20 min; the others had a history of thrombotic complications. A defect of platelet aggregation induced by ADP, epinephrine, collagen and arachidonic acid was documented in the
Waldenstrom's disease
case whose
lupus
anticoagulant was an IgM. In the others,
lupus
anticoagulant, identified as IgG immunoglobulins, produced no aggregation abnormalities. However, beta-thromboglobulin levels in platelets, plasma and urine were consistent with a pattern of platelet activation in all cases. IgG immunoglobulins separated from sera of 6 patients showed
lupus
anticoagulant activity, with no effects on platelet aggregation of normal platelet-rich plasma, but they induced secretion of beta-thromboglobulin from normal platelets.
...
PMID:Interaction between platelets and lupus anticoagulant. 296 26